News about Global Pharma

BD Spins Off Biosciences and Diagnostics Business in USD 17.5B Merger with Waters

Becton, Dickinson and Company (BD) and Waters Corporation have entered into a definitive agreement to merge BD’s Biosciences and Diagnostic Solutions business with Waters in a deal valued at approximately USD 17.5 billion.

Global Pharma | 18/07/2025 | By Dineshwori |  1002

Lupin Receives GMP Certification from TGA Australia for Dabhasa API Facility in Gujarat

Lupin’s wholly-owned subsidiary, Lupin Manufacturing Solutions, has received GMP certification from Australia’s Therapeutic Goods Administration (TGA) for its API facility in Dabhasa, Gujarat.

Global Pharma | 18/07/2025 | By Mrinmoy Dey |  351

Novartis Names Mukul Mehta as Chief Financial Officer as Harry Kirsch Retires After 22 Years

Novartis has announced the appointment of Mukul Mehta as Chief Financial Officer (CFO) and member of the Executive Committee of Novartis (ECN), effective March 16, 2026.

Global Pharma | 17/07/2025 | By Dineshwori |  460

Sanofi India, Emcure Sign Exclusive Distribution Partnership for Anti-Diabetic Drugs

Sanofi India Ltd. has entered into an exclusive distribution and promotion agreement with Emcure Pharmaceuticals for its oral anti-diabetic brands, including Amaryl and Cetapin, aiming to expand patient access and strengthen diabetes care across India.

Global Pharma | 17/07/2025 | By Mrinmoy Dey |  375

GSK Secures FDA Approval for Prefilled Syringe Version of Shingles Vaccine Shingrix

GSK has received approval from the US Food and Drug Administration (FDA) for a new prefilled syringe presentation of Shingrix (Recombinant Zoster Vaccine, RZV), designed to prevent shingles (herpes zoster).

Global Pharma | 17/07/2025 | By Dineshwori |  516

Johnson and Johnson Reports Over 18 Percent Jump in Q2 Earnings

Johnson and Johnson has reported its second-quarter 2025 results, with net earnings soaring 18.2 percent to USD 5.54 billion, up from USD 4.69 billion in the same period last year.

Global Pharma | 17/07/2025 | By Dineshwori |  270

Amphastar to Expand US Manufacturing Footprint, Quadruple Production Capacity

Amphastar Pharmaceuticals aims to quadruple its production capacity at its headquarters in Rancho Cucamonga, California over the next three to five years.

Global Pharma | 16/07/2025 | By Dineshwori |  221

FDA to Review GSK's Application to Expand Arexvy RSV Vaccine Use

The US Food and Drug Administration (FDA) has accepted to review GlaxoSmithKline (GSK)'s application to expand the use of its RSV vaccine, Arexvy, to include adults aged 18–49 who are at increased risk.

Global Pharma | 16/07/2025 | By Dineshwori |  276

Biocon Biologics Secures FDA Approval for Kirsty

Biocon Biologics has announced that it has received FDA approval for KIRSTY (Insulin Aspart-xjhz), making it the first and only interchangeable biosimilar to NovoLog in the US, marking a major milestone in expanding affordable insulin options.

Global Pharma | 16/07/2025 | By Mrinmoy Dey |  298

Emcure Pharma Taps Industry Veteran R.S. Vasan to Lead India Business

Emcure Pharmaceuticals Ltd. has appointed R.S. Vasan as President – India Business and Senior Management Personnel (SMP).

Global Pharma | 16/07/2025 | By Dineshwori |  456